Benchling
includes Benchling AI
9 statements across 1 episodes · 4 bullish · 2 bearish · 1 people on the record · first statement Nov 13, 2025 by Sajith Wickramasekara · said 41 times in 3 episodes since 2023 · across every show →
Mentions by year, the whole family
brought up most by Sarah Guo (32), Sajith Wickramasekara (8), Elad Gil (1)
tap a year for its mentions
2025 39 mentions in 1 episode
2024 1 mention in 1 episode
2023 1 mention in 1 episode
Everything said about Benchling, oldest first
Nov 13, 2025 bullish
Wickramasekara: AI in scientific discovery will focus on augmentation over autonomy next 1-2 years
“While I would love for that to happen, and I'm maybe more optimistic on a longer time scale, we will get there. I think in the short term, I'm next one to two years, which, you know, already feels like an eternity in AI time. I'm a little bit more bullish on s…”
Nov 13, 2025 negative
Nov 13, 2025 positive
Wickramasekara: Benchling AI saved a customer an 8-month redundant mouse study
“We had a customer that was getting ready to run some mouse studies, and they were looking at 20 different mouse models, and they used a deep research our deep research capability to look at all the historical mouse studies that they had run, and it turned out …”
Nov 13, 2025 bullish
Wickramasekara: Benchling released a deep research AI agent over lab data
“And so we've released this deep research agent. It works similar to the deep research agents from Anthropic and other foundation labs. But what it does is it works over Benchling data with the context of the Benchling data model.”
Nov 13, 2025 bullish
Wickramasekara: AI will convert life sciences skeptics to structured data tools
“But now with like AI, one, I think the benefits are a much more immediately obvious to everyone. And so that's going to be this amazing tailwind to try to like do better here. And I think it will convince a lot of people who might have been skeptics in the pas…”
Nov 13, 2025 bearish
Wickramasekara: Pure AI biology model companies must morph into biopharma
“I think it's unlikely, it's possible, but it's unlikely that sort of, hey, they're just gonna remain pure model companies who just do deals with pharma, where pharma, you know, pays them a hundred million dollars upfront or something like that, and they have f…”
Nov 13, 2025
Benchling serves 1,300 biopharma companies and 7,000 academic institutions
“Today we work with about 1300 biotech and pharma companies scientists at over 7000 academic institutions, universities, all, all around the world. And our software powers, you know, household names like Moderna and Sanofi and Eli Lilly and Regeneron, but also …”
Nov 13, 2025 neutral
Wickramasekara: Biology AI has powerful models but lacks a ChatGPT-like interface
“I think we're like, we've got GPT, but there's no chat. Like, that, that's kind of how I think about it. Like, I think the chat, and I mean chat metaphorically, like, that was the interface that made things really take off in, in software. And I don't think it…”